Date of Award
2026
Document Type
Thesis
Publisher
Santa Clara : Santa Clara University, 2026
Department
Bioengineering
First Advisor
Prashanth Asuri
Abstract
Deep Vein Thrombosis (DVT) affects up to almost one million individuals in the United States annually and can lead to life-threatening complications, such as a pulmonary embolism. DVT occurs when a thrombus composed of platelets and fibrin forms within deep veins, obstructing blood flow. Current treatments include anticoagulants, thrombolytics, inferior vena cava filters, and balloon catheter procedures. However, the development and testing of these medical devices heavily rely on animal blood models due to physiological similarities in coagulation, raising ethical concerns and limitations related to cost, scalability, and sustainability. This project proposes a synthetic, in vitro alternative using agarose and dextran based hydrogels to replicate the mechanical and viscoelastic properties of blood clots. By varying polymer concentrations and validating properties through rheological testing, we aim to create reproducible, stable clot models for balloon catheter evaluation. This approach reduces animal dependence while promoting ethical, scalable, and sustainable practices in biomedical device testing.
Recommended Citation
Garcia, Xiomara; Urbina, Jasmine; and Wolf, Sapna, "Development of in vitro Hydrogel Blood Clots" (2026). Bioengineering Senior Theses. 148.
https://scholarcommons.scu.edu/bioe_senior/148
